Diagnosis and Natural History Study of Patients With Neurological Conditions
Primary Purpose
Alzheimer's Disease, Dementia, Movement Disorder
Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Alzheimer's Disease focused on measuring Movement Disorders, Parkinson's, Alzheimer's, Screening, Diagnostic Puzzles, Alzheimer Disease, Progressive Supranuclear Palsy, PSP, Restless Leg Syndrome, RLS, Parkinsonism, PD
Eligibility Criteria
INCLUSION CRITERIA: Patients may be included on this protocol if they have an identifiable neurological disorder or represent a diagnostic puzzle. These disorders would include patients with Parkinson's disease, Alzheimer's disease, multiple system atrophy, progressive supranuclear palsy, restless legs syndrome, other cognitive and movement disorders, and diagnostic puzzles. Patients 18-90 years of age, inclusive, are eligible.
Sites / Locations
- National Institute of Neurological Disorders and Stroke (NINDS)
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00001549
First Posted
November 3, 1999
Last Updated
March 3, 2008
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
1. Study Identification
Unique Protocol Identification Number
NCT00001549
Brief Title
Diagnosis and Natural History Study of Patients With Neurological Conditions
Official Title
Diagnosis and Natural History Protocol for Patients With Neurological Conditions
Study Type
Observational
2. Study Status
Record Verification Date
January 2006
Overall Recruitment Status
Completed
Study Start Date
October 1995 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 2006 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to improve understanding of neurological conditions. Patients participating in this study will continue receiving medical care, routine laboratory tests, and diagnostics tests (X-rays, CT-scans, and nuclear imaging), from their primary care physician. Doctors at the NIH plan to follow these patients and offer advice and assistance to their primary care physicians.
Detailed Description
The objective of this protocol is to provide diagnosis and follow Experimental Therapeutics Branch (ETB) patients not currently entered on another research protocol. No investigational treatments will be administered on this protocol, and the NIH physicians will be playing largely a consultative role to the patient's primary physician.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer's Disease, Dementia, Movement Disorder, Multiple System Atrophy, Parkinson's Disease
Keywords
Movement Disorders, Parkinson's, Alzheimer's, Screening, Diagnostic Puzzles, Alzheimer Disease, Progressive Supranuclear Palsy, PSP, Restless Leg Syndrome, RLS, Parkinsonism, PD
7. Study Design
Enrollment
600 (false)
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
INCLUSION CRITERIA:
Patients may be included on this protocol if they have an identifiable neurological disorder or represent a diagnostic puzzle. These disorders would include patients with Parkinson's disease, Alzheimer's disease, multiple system atrophy, progressive supranuclear palsy, restless legs syndrome, other cognitive and movement disorders, and diagnostic puzzles.
Patients 18-90 years of age, inclusive, are eligible.
Facility Information:
Facility Name
National Institute of Neurological Disorders and Stroke (NINDS)
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20892
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Diagnosis and Natural History Study of Patients With Neurological Conditions
We'll reach out to this number within 24 hrs